文献速递其他结缔组织病

胱硫醚γ-裂解酶依赖性Smad3 S-硫化修饰缓解系统性硬化症纤维化

Cystathionine γ-Lyase-Dependent S-Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis.
PubMed 文献 · Arthritis Rheumatol · 2026-02-22

该研究探讨CSE/H2S轴在系统性硬化症(SSc)中的作用及机制。SSc患者血清CSE/H2S水平降低,S-硫化修饰整体减少;CSE过表达通过增加Smad3的S-硫化修饰抑制TGFβ1/Smad3信号,减轻皮肤和肺纤维化,Smad3 Cys121为关键修饰位点。

要点

  • SSc患者CSE/H2S水平降低,S-硫化修饰整体减少。
  • CSE过表达通过Smad3 S-硫化修饰抑制TGFβ1/Smad3信号。
  • Smad3 Cys121突变削弱CSE的抗纤维化效应。

核心结论

  • Smad3的S-硫化修饰介导CSE在SSc中的抗纤维化作用,是潜在治疗靶点。

研究设计与样本

  • 研究检测25例SSc患者和28例健康对照血清CSE/H2S水平。
  • 使用SSc和健康对照人真皮成纤维细胞进行功能研究,结合LC-MS/MS S-硫化蛋白质组学。
  • 构建博来霉素诱导的小鼠皮肤和肺纤维化模型评估CSE过表达效果。

主要发现

  • SSc患者血清CSE/H2S水平降低,CSE抑制促进细胞外基质沉积。
  • SSc中S-硫化修饰水平整体低于对照。
  • CSE过表达增加Smad3 S-硫化修饰,抑制TGFβ1/Smad3信号,减轻皮肤纤维化。
  • Smad3 Cys121被鉴定为S-硫化关键靶点,其突变损害抗纤维化效应。
  • 小鼠中CSE过表达减轻博来霉素诱导的皮肤和肺纤维化。

临床怎么用

  • 靶向CSE/H2S轴或Smad3 S-硫化修饰可能成为SSc纤维化的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The cystathionine γ-lyase (CSE)/hydrogen sulfide (H2S) axis has emerged as a key regulator in tissue fibrogenesis. This study aimed to explore the role of the CSE/H2S axis in systemic sclerosis (SSc) and to investigate its underlying mechanisms to identify promising therapeutic targets. METHODS: CSE/H2S levels were assessed in serum samples from 25 patients with SSc and 28 healthy controls. Human dermal fibroblasts from patients with SSc and healthy controls were used for functional studies, including propargylglycine (CSE inhibitor) treatment, Gyy4137, a slow-releasing hydrogen sulfide donor, CSE silencing, and CSE overexpression, combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based S-sulfhydration proteomics. Molecular dynamics simulations were performed to study the effects of S-sulfhydration on protein structure, and an Smad3 C121S (cysteine [Cys] 121 mutated to Ser) mutant was generated to verify the function targets of S-sulfhydration. In vivo, bleomycin-induced mouse models of skin and lung fibrosis were constructed to evaluate the effects of CSE overexpression. RESULTS: In human samples, CSE/H2S levels were reduced in SSc. CSE inhibition promoted extracellular matrix deposition. S-sulfhydration proteomics showed that S-sulfhydration levels were globally reduced in SSc compared to controls. CSE overexpression increased S-sulfhydration on Smad3, suppressed transforming growth factor β 1 (TGFβ1)/Smad3 signaling, mitigating skin fibrosis. Notably, Cys121 on Smad3, identified as a pivotal target for S-sulfhydration by proteomics, was shown to fine-tune its MH1 domain, with its mutation impairing the antifibrotic effects. In mice, CSE overexpression attenuated bleomycin-induced skin and lung fibrosis. CONCLUSION: Smad3 S-sulfhydration mediates the antifibrotic effect of CSE in SSc, highlighting it as a critical mechanism and promising therapeutic target.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Liu J, Xiao Y, Liu L, et al. Cystathionine γ-Lyase-Dependent S-Sulfhydration of Smad3: A Novel Target to Alleviate Fibrosis in Systemic Sclerosis. Arthritis Rheumatol. 2026. PMID: 41657106. doi:10.1002/art.70085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。